Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05788887
Other study ID # BAP20060569
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 10, 2022
Est. completion date January 17, 2022

Study information

Verified date April 2023
Source University of the Aegean
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study was the investigation of the postprandial metabolic responses, after the intake of a traditional, Ladotyri Mytilinis cheese, compared to corresponding responses after an Italian Parmesan cheese consumption, in healthy participants.


Description:

A pilot cross-over, randomized and single-blinded, intervention-clinical trial was conducted, in ten healthy men and women subjects, aged eighteen to thirty years, after random allocation into the control and the intervention group, received a high-fat and carbohydrates meal, containing Ladotyri Mytilinis (the authentic nonrefrigerated recipe) or Italian Parmesan, PDO cheeses. After a washout week, participants consumed the same meals, conversely. Differences on postprandial responses of serum total, High Density Lipoprotein (HDL-), Low Density Lipoprotein (LDL-) cholesterol, glucose, triglycerides and uric acid levels, as well as of plasma total antioxidant capacity according to Ferric Reducing Antioxidant Power method, were determined between groups in fasting, thirty minutes, one and a half hour, and three hours after meal intake.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date January 17, 2022
Est. primary completion date January 17, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Age 18-65 years - Willingness to join and complete the nutritional intervention Exclusion Criteria: - Inability or unwillingness to provide informed consent - Three-month nutritional supplement - Age over 65 years or below 18 years - Chronic diseases history - Hemoglobin A1c - HbA1c > 5.7 % - Abnormal Body Mass Index (BMI) (> 25 kg / m2) - Abnormal hematological or biochemical profile (total cholesterol > 240 mg/dL, triglycerides > 250 mg/dL, glucose > 100 mg/dL) - Alcohol overdose (> 40 g alcohol / day) - Heavy smoking (> 10 cigarettes / day) - Concurrent participation in another intervention study or unconsciousness in previous blood draws

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Authentic Ladotyri Mytilinis PDO cheese
Branding PDO cheese from Mytilini, purchasing by E.Thimelis Dairy S.A.
Control
Branding Parmesan PDO cheese from Italy, supplied by LIDL Hellas

Locations

Country Name City State
Greece University of the Aegean Myrina

Sponsors (2)

Lead Sponsor Collaborator
University of the Aegean E.Thimelis Dairy S.A.

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes from baseline of Total Antioxidant Capacity at 30 minutes, 1.5 hours and 3 hours Plasma antioxidant activity 3 hours
Secondary Changes from baseline of total Cholesterol at 30 minutes, 1.5 hours and 3 hours Serum total cholesterol levels 3 hours
Secondary Changes from baseline of High Density Lipoprotein cholesterol (HDL-) at 30 minutes, 1.5 hours and 3 hours Serum High Density Lipoprotein levels 3 hours
Secondary Changes from baseline of Low Density Lipoprotein cholesterol (LDL-) at 30 minutes, 1.5 hours and 3 hours Serum High Density Lipoprotein levels 3 hours
Secondary Changes from baseline of triglycerides at 30 minutes, 1.5 hours and 3 hours Serum triglycerides levels 3 hours
Secondary Changes from baseline of glucose at 30 minutes, 1.5 hours and 3 hours Serum glucose levels 3 hours
Secondary Changes from baseline of Uric Acid at 30 minutes, 1.5 hours and 3 hours Serum uric acid levels 3 hours
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1